Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.
about
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsElucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry dataNatural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the AgedNew criteria for response assessment: role of minimal residual disease in multiple myelomaThe myeloma stem cell concept, revisited: from phenomenology to operational termsHigh-resolution antibody dynamics of vaccine-induced immune responsesB cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationGenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.Paradoxical aging in HIV: immune senescence of B Cells is most prominent in young age.Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease featuresComparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh.Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytesCell communication using intrinsically disordered proteins: what can syndecans say?Altered distribution of peripheral blood memory B cells in humans chronically infected with Trypanosoma cruziMass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.Proportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIV-uninfected but exposed children.Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.Advances in human B cell phenotypic profiling.Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets.Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.B cell responses to the 2011/12-influenza vaccine in the aged.Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females.Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials.Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets.Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulationsDifferential effects of lenalidomide during plasma cell differentiationKruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele.Development of Plasmodium falciparum specific naïve, atypical, memory and plasma B cells during infancy and in adults in an endemic area.The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53Immunophenotyping in multiple myeloma and related plasma cell disorders.Human lymphocyte repertoires in ageing.Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myelomaValidation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in manThe human counterpart of mouse B-1 cells.Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
P2860
Q24604720-B9EDFFE3-D427-4E67-81FF-FD3042A3F118Q24605194-6912EE0D-8647-4F57-B1FF-028F19719019Q26752508-D0613BBC-3F5A-4B99-803A-8A2502AD66B8Q27027512-CFFD0375-2CC7-4852-95E8-D7A08C37AC22Q28076070-C60D0C98-42F9-4D24-84DE-6C7555F2C379Q28660366-5A8E8F9F-7594-476A-A240-0EA81AE3D70BQ30429248-192ACA5D-909B-4BB5-BA33-9B57C4841787Q30886634-51E9FF1E-ADB0-4E54-B019-65A84CCFAA1EQ33657511-24C36FB9-FF57-45D8-82E3-55A1E7555759Q34233791-71A5E8A6-4C58-4337-8967-B1198E2025D9Q34543082-C29C4383-4578-46CC-ACB1-BACFA0919440Q35138801-22F77C25-B1BB-4DC2-BBDD-04CDCF36737CQ35156154-8336DDA1-A13C-4116-9675-032336B806C4Q35193252-93D25883-CF1F-4506-84B5-FE991594AA90Q35222938-F52B2476-4CB9-4681-8B46-C65722692B96Q35688965-79A5BE5C-DCDD-4F98-A734-BBF7008DFABEQ35758085-C7A14DBB-80AA-4E3A-8965-D662FC845BF9Q35874111-414CB6D8-A449-40E4-A326-CB6ED797464BQ35963125-D23FF36B-3C79-4D22-A700-5AEA4A5DFBF6Q36051992-F91799A4-8CFB-4EA3-9316-CD952C00CEF0Q36307080-57835033-C052-4C05-870D-506AA7EB24C9Q36430118-C1A6F19E-4435-4EE1-B7D3-A80C2CC234B9Q36498366-409AFCFF-51A6-4436-842F-65112C81DC61Q36774876-CCDABC73-A860-4EC8-8405-6ABDB7B7F05BQ36827309-EB689145-45BD-48F2-A9AB-217DB761DDEBQ36950617-6E824C16-3581-4624-91B3-0C65EE1B3CF8Q37078432-A1F765B7-F2EE-4151-8887-3C49A38E2FF7Q37219293-C0643144-5BE6-4B0B-BB37-2360B7766B61Q37254327-CE7933CD-C7E5-408B-BDD4-90C7EF19978FQ37317494-03721902-FF78-42B5-8BC1-5681B75D06E9Q37558285-67807DC6-D321-4598-9F52-FCBE980FD922Q37597307-09ED8971-69CA-4F92-8705-D01AB23518BAQ37630230-81E77CB1-BB5E-4184-AD8F-B590AC533DBDQ37706993-55C57228-3920-481E-B771-81EAE90601F9Q37812870-4575F12A-D681-4961-AB2B-C6B006CA9F08Q38132993-F41B73B9-9506-45B8-A19B-B149E6B70889Q38219408-C5783AEA-757F-451D-A22F-81F33250120EQ38309297-CA6D3885-D945-44E1-88C3-692FBD4E5295Q38491162-2751EDDD-853B-4EE5-B467-5AE4FE12309AQ38534837-195E962E-CF2E-4661-9C23-84ADC7366AEF
P2860
Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@ast
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@en
type
label
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@ast
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@en
prefLabel
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@ast
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@en
P2093
P2860
P1433
P1476
Circulating human B and plasma ...... D138- and CD138+ plasma cells.
@en
P2093
Alberto Orfao
Alexander Schmitz
Anouk Caraux
Bernard Klein
Bruno Paiva
Caroline Bret
Gwenny M Fuhler
Martin Perez-Andres
Myeloma Stem Cell Network
Nico A Bos
P2860
P304
P356
10.3324/HAEMATOL.2009.018689
P577
2010-01-15T00:00:00Z